Skip to main content

Table 1 Patient profile of parallel comparison

From: Identification of mosaic and segmental aneuploidies by next-generation sequencing in preimplantation genetic screening can improve clinical outcomes compared to array-comparative genomic hybridization

Patient number

45

Mean female age (years)

35.5 (21–42)

Baseline AMH(ng/mL)a

4.0 ± 3.7

Antral follicle counta

8.9 ± 4.4

Indicationsb

 Severe male factor

5 (11.1%)

 Advanced female age (≧36 years)

20 (44.4%)

 Repeated implantation failure

14 (31.1%)

 Donated-oocyte recipient for single embryo transfer

6 (13.3%)

Number of embryos biopsied (≧ grade BC)

182

Number of embryos with WGA failure

4

Number of embryos screened by PGS

178

  1. AMH anti-Mullerian hormone, WGA whole genome amplification, PGS preimplantation genetic screening
  2. aData are presented as mean ± SD
  3. bData are presented as the number of the class (percentage of the class)